Sachin S Shenoy1, Andrew Gilliam2, Ahmed Mehanna3, Venkatesh Kanakala4, Gopinath Bussa5, Talvinder Gill5, Katherine Sanderson6, Y K S Viswanath7,8, Venkatesh Shanmugam5. 1. Department of Surgery, County Durham and Darlington NHS Foundation Trust, Darlington, UK. 2. County Durham and Darlington NHS Foundation Trust, Darlington, UK. 3. Department of Surgery, James Cook University Hospital, Middlesbrough, UK. 4. James Cook University Hospital, South Tees Hospital NHS Foundation Trust, Middlesbrough, UK. 5. North Tees and Hartlepool NHS Foundation Trust, Stockton on Tees, UK. 6. SHSC Women and Children's Health/Public Health, Teesside University, Middlesbrough, UK. 7. James Cook University Hospital, South Tees Hospital NHS Foundation Trust, Middlesbrough, UK. yksviswanath@nhs.net. 8. Endoscopy Suites, James Cook University Hospital, Middlesbrough, Cleveland, TS43BW, UK. yksviswanath@nhs.net.
Abstract
INTRODUCTION: Obesity is a chronic disease due to excess fat storage, a genetic predisposition, and environmental contribution where surgery offers a viable treatment option. The surgical treatment of obesity in the elderly population (> 55 years) remains controversial. PURPOSE: To evaluate the safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in elderly bariatric patients. MATERIALS AND METHODS: Data was sourced from MEDLINE, EMBASE, CINAHL, PubMed, and Cochrane databases for peer-reviewed, randomized controlled trials, and observational studies in the English language were searched from the year 1991 until 2019. From the extracted data, early and late procedural complications and mortality were used as safety outcomes. Weight loss was the primary outcome for effectiveness while the resolution of obesity-related comorbidities was included as secondary outcomes. The Review Manager (Rev Man 5.3)™ software was used for statistical analysis. RESULTS: Of the forty-one screened studies, nine studies were included in the final analysis. There was no difference between LSG and LRYGB regarding early complications and mortality 3.6% versus 5.8% (p = 0.15) and 0.1% versus 0.8% (p = 0.27). Patients who underwent LRYGB had more late complications compared with those who underwent LSG (0.07% and 0.03%, p = 0.001). There was no difference in terms of weight loss at the end of 1 year. Patients who underwent LRYGB had a better resolution of obesity-related comorbidities, not statistically significant. CONCLUSION: LRYGB has better efficacy when compared with LSG. However, high-risk elderly patients should be considered for LSG given the lesser morbidity and comparable efficacy with LRYGB.
INTRODUCTION:Obesity is a chronic disease due to excess fat storage, a genetic predisposition, and environmental contribution where surgery offers a viable treatment option. The surgical treatment of obesity in the elderly population (> 55 years) remains controversial. PURPOSE: To evaluate the safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in elderly bariatric patients. MATERIALS AND METHODS: Data was sourced from MEDLINE, EMBASE, CINAHL, PubMed, and Cochrane databases for peer-reviewed, randomized controlled trials, and observational studies in the English language were searched from the year 1991 until 2019. From the extracted data, early and late procedural complications and mortality were used as safety outcomes. Weight loss was the primary outcome for effectiveness while the resolution of obesity-related comorbidities was included as secondary outcomes. The Review Manager (Rev Man 5.3)™ software was used for statistical analysis. RESULTS: Of the forty-one screened studies, nine studies were included in the final analysis. There was no difference between LSG and LRYGB regarding early complications and mortality 3.6% versus 5.8% (p = 0.15) and 0.1% versus 0.8% (p = 0.27). Patients who underwent LRYGB had more late complications compared with those who underwent LSG (0.07% and 0.03%, p = 0.001). There was no difference in terms of weight loss at the end of 1 year. Patients who underwent LRYGB had a better resolution of obesity-related comorbidities, not statistically significant. CONCLUSION: LRYGB has better efficacy when compared with LSG. However, high-risk elderly patients should be considered for LSG given the lesser morbidity and comparable efficacy with LRYGB.
Authors: Mika Helmiö; Mikael Victorzon; Jari Ovaska; Marja Leivonen; Anne Juuti; Nabil Jaser; Pipsa Peromaa; Pekka Tolonen; Saija Hurme; Paulina Salminen Journal: Surg Endosc Date: 2012-04-05 Impact factor: 4.584
Authors: James Yoon; Jingjing Sherman; Alexandra Argiroff; Edward Chin; Daniel Herron; William Inabnet; Subhash Kini; Scott Nguyen Journal: Obes Surg Date: 2016-11 Impact factor: 4.129
Authors: Ralph Peterli; Yves Borbély; Beatrice Kern; Markus Gass; Thomas Peters; Martin Thurnheer; Bernd Schultes; Kurt Laederach; Marco Bueter; Marc Schiesser Journal: Ann Surg Date: 2013-11 Impact factor: 12.969
Authors: Adrienne N Christopher; Martin P Morris; Viren Patel; Harrison Davis; Robyn B Broach; John P Fischer Journal: Aesthetic Plast Surg Date: 2021-02-05 Impact factor: 2.326